Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat diet-induced type 2 diabetic C57BL/6J mice (Q44800245)

6 December 2017

title

Antihyperglycemic effect of carvacrol in combination with rosiglitazone in high-fat diet-induced type 2 diabetic C57BL/6J mice (English)

1 reference

6 December 2017

1 reference

Muthukrishnan Ezhumalai

series ordinal

1

1 reference

6 December 2017

Thangaiyan Radhiga

series ordinal

2

1 reference

6 December 2017

Kodukkur Viswanathan Pugalendi

series ordinal

3

1 reference

6 December 2017

publication date

22 September 2013

1 reference

Molecular and Cellular Biochemistry

6 December 2017

published in

1 reference

6 December 2017

volume

385

1 reference

6 December 2017

issue

1-2

1 reference

6 December 2017

page(s)

23-31

1 reference

Global estimates of the prevalence of diabetes for 2010 and 2030

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Pathogenesis of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

The high-fat-fed lean Zucker rat: a spontaneous isocaloric model of fat-induced insulin resistance associated with muscle GSK-3 overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

PPARs: therapeutic targets for metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Carvacrol, a component of thyme oil, activates PPARalpha and gamma and suppresses COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Determination of Glucose in Blood Using Glucose Oxidase with an Alternative Oxygen Acceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

A new colorimetric method for the estimation of glycosylated hemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

One-step sandwich enzyme immunoassay for insulin using monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Estimation of plasma phosphatase by determination of hydrolysed phenol with amino-antipyrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

The rat model of type 2 diabetic mellitus and its glycometabolism characters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Quantitative study of insulin secretion and clearance in normal and obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Surgical removal of visceral adipose tissue: effects on insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Carvacrol prevents diet-induced obesity by modulating gene expressions involved in adipogenesis and inflammation in mice fed with high-fat diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Hypoglycemic agent YM440 suppresses hepatic glucose output via gluconeogenesis by reducing glucose-6-phosphatase activity in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Regulation of metabolic pathways in liver and kidney during experimental diabetes: Effects of antidiabetic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Review article: the metabolic syndrome and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

A prospective study of the causes of notably raised aspartate aminotransferase of liver origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Effect of carvacrol on hepatic marker enzymes and antioxidant status in D-galactosamine-induced hepatotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Prospective Study of Serum -Glutamyltransferase and Risk of NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1810-8

Pathological occurrence of glucose-6-phosphatase in serum in liver diseases

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Obesity as a medical problem

1 reference

12 December 2020

Enhancement of the antineoplastic effect of anticarcinogens on benzo[a]pyrene-treated Wistar rats, in relation to their number and biological activity

1 reference

12 December 2020

Fructose-1,6-diphosphatase, phosphofructokinase and glucose-6-phosphate dehydrogenase from fermenting and non fermenting yeasts.

1 reference

12 December 2020

The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages

1 reference

12 December 2020

Mechanisms of hypoglycemic activity of aconitan A, a glycan from Aconitum carmichaeli roots

1 reference

12 December 2020

A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases

1 reference

12 December 2020

Defining high-fat-diet rat models: metabolic and molecular effects of different fat types

1 reference

12 December 2020

Serum γ-glutamyl transpeptidase activity in alcoholism

1 reference

12 December 2020

Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat.

1 reference

12 December 2020

Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin

1 reference

12 December 2020

10.1007/S11010-013-1810-8

Identifiers

DOI

1 reference

6 December 2017

1 reference